IPCA Laboratories Q1 FY23 consolidated PAT higher at Rs. 143.06 Cr
The company has reported total income of Rs. 1607.85 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 1607.85 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 317.45 crores during the period ended June 30, 2022
The company has reported total income of Rs. 28.20 crores during the period ended June 30, 2022.
The WAVEsystem with the WAVEcontrol 4.0 embedded
The facility is designed with advanced analytical equipment to provide testing services such as In-vitro Permeation testing
Dr. Lal Path Labs has reported total income of Rs. 511 crores during the period ended June 30, 2022
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
Merck’s first microbiology application and training lab in India
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
Subscribe To Our Newsletter & Stay Updated